Avivagen Inc. announced that its Board of Directors has appointed Cameron Groome as Chief Executive Officer and President and will be nominating Mr. Groome for appointment to the Board of Directors at the company's next Annual General Meeting of Shareholders. Mr. David Hankinson, who is succeeded by Cameron in the CEO role, is committed to supporting Cameron and the company in achieving the next level of success by accepting the newly created role of Executive Director. Dr. Graham Burton is succeeded by Mr. Groome in the role of President and will now be taking on the newly created role of Director of Commercialization Science.

Previously, Cameron was Executive Vice President, Corporate and Strategic Development for Bioniche Life Sciences Inc.